OPK Q1 2024 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena

OPKOPKO Health, Inc.

$933M

Q1 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$174M-26.9% YoY

Gross Profit

$42M24.2% margin

Operating Income

-$71M-41.2% margin

Net Income

-$82M-47.1% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-4.5%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$40M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$721M

Stockholders' Equity

$1.3B

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$174M	$238M	-26.9%
Gross Profit	$42M	$99M	-57.6%
Operating Income	-$71M	-$31M	-133.6%
Net Income	-$82M	-$18M	-348.0%

Revenue Segments

Service

$127M73%

Product

$38M22%

Transfer of Intellectual Property and Other

$9M5%

Geographic Segments

UNITED STATES

$136M78%

CHILE

$15M9%

IRELAND

$9M5%

MEXICO

$7M4%

SPAIN

$6M3%

Other Countries

$630,0000%

ISRAEL

$160,0000%